Experimental canine cancer drug could help humans, too

08/7/2013 | News-Gazette (Champaign-Urbana, Ill.), The

University of Illinois chemist Paul Hergenrother developed an anti-cancer drug, PAC-1, that has shown promise for treatment of cancer in dogs at the University of Illinois Veterinary Teaching Hospital. Veterinary oncologist and trial coordinator Tim Fan says the drug was evaluated in dogs who had advanced blood or bone cancers that had metastasized to lung tissue. The drug works by triggering cell death, and researchers plan to evaluate its use for treatment of brain cancer in humans.

View Full Article in:

News-Gazette (Champaign-Urbana, Ill.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC